Flower City Capital holds a concentrated book of 49 stocks worth $227.1M as of Q2 2026 (disclosed Jul 7, 2026, a ~45-day 13F lag). This quarter they opened Regeneron Pharmaceuticals and trimmed Vanguard S&P 500 ETF. Their largest long position is Vanguard Russell 1000 at 36% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1808394/holdings"
Use Arkolith to show Flower City Capital's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
6% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Vanguard Scottsdale FDS VNG RUS1000IDX | $82.7M | 244.1K | 36.4% | ▲+1.4% Added · +3K sh | |
| 2 | Vanguard Intl Equity Index F ALLWRLD EX US | $69.3M | 826.9K | 30.5% | ▲+1.1% Added · +9K sh | |
| 3 | Vanguard Index FDS S&P 500 ETF SHS | $16.4M | 23.8K | 7.2% | ▼−1.3% Reduced · −309 sh | |
| 4 | Ishares TR CORE S&P500 ETF | $9.1M | 12.2K | 4.0% | ▼−0.8% Reduced · −103 sh | |
| 5 | Vanguard Intl Equity Index F FTSE SMCAP ETF | $6.3M | 41.1K | 2.8% | ▼−1.3% Reduced · −557 sh | |
| 6 | Ishares TR MSCI EAFE ETF | $5.9M | 56.8K | 2.6% | ▼−1.3% Reduced · −752 sh | |
| 7 | Apple Inc COM | $4.1M | 14.0K | 1.8% | ▼−6.7% Reduced · −1K sh | |
| 8 | Vanguard Admiral FDS Inc SMLLCP 600 IDX | $4.0M | 28.8K | 1.7% | ▼−0.2% Reduced · −61 sh | |
| 9 | Schwab Strategic TR US LRG CAP ETF | $3.7M | 125.6K | 1.6% | ▼−0.2% Reduced · −269 sh | |
| 10 | Vanguard Index FDS LARGE CAP ETF | $3.4M | 9.9K | 1.5% | ▲+5.5% Added · +513 sh | |
| 11 | Vanguard Star FDS VG TL INTL STK F | $1.9M | 22.3K | 0.8% | ▲+5.8% Added · +1K sh | |
| 12 | Vanguard Tax-Managed FDS VAN FTSE DEV MKT | $1.8M | 24.6K | 0.8% | —Held | |
| 13 | Nvidia Corporation COM | $1.5M | 7.4K | 0.7% | ▲+0.5% Added · +36 sh | |
| 14 | Vanguard Index FDS TOTAL STK MKT | $1.4M | 3.8K | 0.6% | ▲+0.9% Added · +35 sh | |
| 15 | Microsoft Corp COM | $1.2M | 3.1K | 0.5% | ▼−2.4% Reduced · −79 sh | |
| 16 | Vanguard Scottsdale FDS VNG RUS2000IDX | $1.1M | 9.5K | 0.5% | ▼−0.1% Reduced · −5 sh | |
| 17 | Amazon Com Inc COM | $998K | 4.2K | 0.4% | ▼−7.4% Reduced · −336 sh | |
| 18 | Schwab Strategic TR INTL EQTY ETF | $979K | 35.3K | 0.4% | —Held | |
| 19 | Vanguard Intl Equity Index F TT WRLD ST ETF | $663K | 4.2K | 0.3% | ▲+1.9% Added · +79 sh | |
| 20 | Vanguard BD Index FDS TOTAL BND MRKT | $656K | 8.9K | 0.3% | ▼−4.0% Reduced · −374 sh | |
| 21 | Vanguard Index FDS GROWTH ETF | $638K | 7.4K | 0.3% | ▲+500% Added · +6K sh | |
| 22 | Alphabet Inc CAP STK CL A | $627K | 1.8K | 0.3% | ▼−22% Reduced · −500 sh | |
| 23 | Chevron Corporation COM | $610K | 3.7K | 0.3% | ▼−3.5% Reduced · −135 sh | |
| 24 | Alphabet Inc CAP STK CL C | $532K | 1.5K | 0.2% | ▲+4.1% Added · +59 sh | |
| 25 | SPDR Series Trust ST STR P500ETF | $525K | 6.0K | 0.2% | —Held | |
| 26 | Ge Aerospace COM NEW | $500K | 1.3K | 0.2% | —Held | |
| 27 | Texas Pacific Land Corporati COM | $481K | 1.1K | 0.2% | —Held | |
| 28 | Ishares TR RUSSELL 2000 ETF | $460K | 1.5K | 0.2% | ▼−1.2% Reduced · −18 sh | |
| 29 | International Business Machs COM | $426K | 1.5K | 0.2% | ▲+29% Added · +340 sh | |
| 30 | Vanguard Index FDS SMALL CP ETF | $422K | 1.4K | 0.2% | ▲+6.4% Added · +84 sh | |
| 31 | Ishares TR U.S. TECH ETF | $409K | 1.6K | 0.2% | —Held | |
| 32 | JPMorgan Chase & Co COM | $401K | 1.2K | 0.2% | ▲+4.8% Added · +56 sh | |
| 33 | Ge Vernova Inc COM | $387K | 329 | 0.2% | —Held | |
| 34 | Berkshire Hathaway Inc Del CL B NEW | $363K | 725 | 0.2% | ▲+4.3% Added · +30 sh | |
| 35 | Schwab Strategic TR US SML CAP ETF | $329K | 9.1K | 0.1% | —Held | |
| 36 | Regeneron Pharmaceuticals COM | $312K | 500 | 0.1% | ▲New New position | |
| 37 | Schwab Strategic TR EMRG MKTEQ ETF | $304K | 8.4K | 0.1% | —Held | |
| 38 | Home Depot Inc COM | $300K | 850 | 0.1% | ▼−23% Reduced · −250 sh | |
| 39 | TPG Inc COM CL A | $290K | 7.2K | 0.1% | —Held | |
| 40 | Immuneering Corp CLASS A COM | $275K | 55.0K | 0.1% | —Held | |
| 41 | Vanguard Index FDS MID CAP ETF | $263K | 3.3K | 0.1% | ▲+299% Added · +2K sh | |
| 42 | Wheaton Precious Metals Corp COM | $239K | 2.1K | 0.1% | —Held | |
| 43 | Gravity Co Ltd SPONSORED ADS NE | $235K | 3.5K | 0.1% | —Held | |
| 44 | Walmart Inc COM | $217K | 1.9K | 0.1% | ▼−0.6% Reduced · −12 sh | |
| 45 | Aon PLC SHS CL A | $203K | 613 | 0.1% | ▲New New position | |
| 46 | Kura Oncology Inc COM | $197K | 18.0K | 0.1% | —Held | |
| 47 | Entravision Communications C CL A | $137K | 10.5K | 0.1% | ▲New New position | |
| 48 | Precigen Inc COM | $114K | 20.0K | 0.1% | —Held | |
| 49 | Outlook Therapeutics Inc COM | $32K | 20.0K | 0.0% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 7, 2026 | 49 | $227.1M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 14, 2026 | 46 | $199.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 22, 2026 | 44 | $196.1M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 8, 2025 | 43 | $186.0M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 39 | $169.6M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 22, 2025 | 38 | $152.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 16, 2025 | 34 | $163.5M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 15, 2024 | 33 | $170.3M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.